Food and Drug Administration management concerns: hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998, Volumes 73-78
U.S. G.P.O., 1998 - Law - 71 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
2000 Computing Crisis agency agency-wide Agency's assets audit report auditors bar code Barton Burr Byrd cardholders CBER CBER's Center for Biologics Chairman committee compliance Congress control objectives correct credit card Defense Computers documents dollar Drug Administration effective employees ensure Evaluation FDA management FDA's financial audit Financial Integrity Act Financial Management financial statements fiscal year 1996 Food and Drug fraud Friedman Ganske going Gramling hearing HHS IG High Risk Series identified IMPAC card individuals Inspector internal controls investigation issued JOE BARTON Klink ledger limit look management systems March 27 material weakness ment million mission Office Okay operations oversight PDUFA personal computer problems procedures procurement Prompt Payment Act property management property management system purchase card question records responsibility RON KLINK Schaub separation of duties specifically Stumphy Stupak subcommittee testimony tion tracking transactions understand